Realtime | Geld | Brief | Zeit |
---|---|---|---|
7,050 | 7,300 | 23:01 | |
7,050 | 7,300 | 22:00 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |
---|---|---|---|---|
Do | WAVE Life Sciences stock holds buy rating, $22 target from H.C. Wainwright | 3 | Investing.com | |
WAVE LIFE SCIENCES Aktie jetzt für 0€ handeln | ||||
Mi | Jefferies maintains Buy on WAVE Life Sciences stock, $26 target | 3 | Investing.com | |
Mi | Wave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next Year | 2 | Benzinga.com | |
Mi | Wave Life Sciences shares surge on positive DMD trial results | 2 | Investing.com | |
Mi | Wave Life Sciences-Aktien steigen nach positiven DMD-Studienergebnissen | 2 | Investing.com Deutsch | |
Mi | Wave Life Sciences: Phase 2 FORWARD-53 Achieves All Trial Goals | 5 | RTTNews | |
Mi | Wave Life Sciences reports progress in DMD treatment | 2 | Investing.com | |
Mi | Wave Life Sciences Ltd. - 8-K, Current Report | 3 | SEC Filings | |
Mi | Wave Life Sciences USA, Inc.: Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531 | 123 | GlobeNewswire (Europe) | |
22.03. | Wave Life Sciences-Direktor Christian Henry verkauft Aktien im Wert von 102.574 US-Dollar | 2 | Investing.com Deutsch | |
10.03. | Mizuho maintains WAVE Life Sciences Outperform rating | 3 | Investing.com | |
08.03. | Wave Life Sciences CEO Paul Bolno verkauft Aktien im Wert von 1,62 Millionen US-Dollar | 6 | Investing.com Deutsch | |
06.03. | Wave Life Sciences (NASDAQ:WVE) Stock Price Down 6.1% - Should You Sell? | 1 | MarketBeat | |
06.03. | H.C. Wainwright maintains $22 target on WAVE Life Sciences stock | 1 | Investing.com | |
05.03. | Wave Life Sciences (NASDAQ:WVE) Trading Up 5.4% on Strong Earnings | 3 | MarketBeat | |
05.03. | Truist maintains Buy rating on WAVE Life Sciences stock, $36 target | 2 | Investing.com | |
04.03. | JPMorgan raises WAVE Life Sciences stock target to $21 | 40 | Investing.com | |
04.03. | Wave Life Sciences Ltd. Q4 Earnings Summary | 1 | RTTNews | |
04.03. | Wave Life Sciences GAAP EPS of $0.17 beats by $0.35, revenue of $83.75M beats by $56.71M | 5 | Seeking Alpha | |
04.03. | Wave Life Sciences USA, Inc.: Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update | 762 | GlobeNewswire (Europe) |